We Are Healthy

Baltimore Cancer Patients Gain 40% More Care

A new $500 million downtown tower adds 62 private rooms and a 48-space infusion center for cancer patients.

Updated on Nov. 18, 2026 in Diseases

Downtown Baltimore hospital tower with a glass and pale stone facade rising above brick low-rise buildings under overcast daylight.
The University of Maryland Medical Center opened its $500 million Roslyn and Leonard Stoler Center for Advanced Medicine in downtown Baltimore in late September, adding 62 private rooms and a 48-space infusion center. AI Illustration. Upload story photo >

Live Poll

Do you trust new local hospital expansions to improve care in your community?

University of Maryland Medical Center has dedicated its $500 million downtown Baltimore cancer facility, the Roslyn and Leonard Stoler Center for Advanced Medicine, a 14-story building that opened to patients in late September 2026. It is intended to serve Baltimore and Maryland patients seeking cancer treatment, with expanded inpatient and outpatient capacity.

Why it matters

The facility's added capacity, with inpatient and outpatient cancer care up 40%, aims to ease access to treatment for patients in Baltimore and across Maryland. Its dedication marks a significant investment in centralized cancer care in the city.

The figures are institutional capacity reports from the medical center at its dedication, not independent measures of care quality. The source does not yet show how the 40% capacity gain translates into shorter waits or better outcomes for patients.

The players

University of Maryland Medical Center

A major Baltimore academic medical center whose cancer programs, including the Greenebaum Comprehensive Cancer Center, provide treatment across a range of cancers.

Roslyn and Leonard Stoler

The namesake family, whose $25 million commitment supports cancer care at the new center.

The details

The 14-story tower houses the Greenebaum Comprehensive Cancer Center across six floors and includes 62 private patient rooms and a 48-space infusion center. The facility includes updated treatment technology and areas designed so patients and caregivers can be together during treatment.

Timeline

  1. Late September 2026: the cancer facility opened to patients.

  2. November 17, 2026: the building was officially dedicated as the Stoler Center.

  3. 2027-2028: expanded clinical trials space and a 24/7 urgent care center are expected to be added.

Cancer Care Landscape

The tower places the Greenebaum Comprehensive Cancer Center in a purpose-built setting with expanded inpatient and outpatient space. Planned clinical trials expansion would add research capacity alongside treatment.

Patients in the Baltimore area facing a cancer diagnosis may find more room for infusion treatment and inpatient care at this facility. If you are considering cancer care, it is worth asking your physician whether a center with expanded capacity and clinical trial options fits your treatment plan.

The takeaway

Expanded capacity at a dedicated cancer center can matter most for patients who need timely infusion or inpatient care. If you have questions about cancer screening or treatment options, raise them with your physician.

What happens next

Expanded clinical trials space and a 24/7 urgent care center are expected to be added over the next two years, 2027-2028.

Further reading

Explore more on Cancer care developments in Baltimore and beyond.

Live Poll

Do you trust new local hospital expansions to improve care in your community?